DQWS DSwiss Inc
Perfumes, Cosmetics & Other Toilet Preparations · OTC · SEC CIK 1652561 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-65.2%
TTM net income YoY-84.8%
TTM EPS YoY-400.0%
Revenue 3-yr CAGR89.9%
Net income 3-yr CAGR—
Margins
Gross margin31.8%
Operating margin-0.0%
Net margin-4.0%
FCF margin0.4%
EBITDA margin3.4%
Returns
ROE-74.1%
ROA-10.1%
ROIC (approx.)—
Asset turnover2.51x
Leverage & solvency
Liabilities / assets91.7%
Debt / equity0.00x
Current ratio0.91x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.13x
Accruals ratio-11.4%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $492,757 | $511,781 | $477,737 | $456,842 | $441,618 | $1.02M | $1.00M | $3.11M |
| Cost of revenue | $298,530 | $342,427 | $318,545 | $362,504 | $383,049 | $872,732 | $738,139 | $926,945 |
| Gross profit | $194,227 | $169,354 | $159,192 | $94,338 | $58,569 | $148,608 | $263,047 | $108,000 |
| SG&A expense | $108,739 | $168,075 | $141,855 | $235,464 | $140,357 | $135,499 | $119,325 | $234,476 |
| Operating income | -$97 | -$148 | -$340 | -$213 | -$355 | -$599 | — | -$260 |
| Pretax income | $75,520 | $149 | $6,974 | -$145,134 | -$90,752 | $34,240 | $140,758 | -$122,887 |
| Income tax | $5,370 | $2,651 | $2,683 | $4,699 | $7,139 | $2,112 | $2,022 | -$7,767 |
| Net income | $70,150 | -$2,502 | $4,291 | -$149,833 | -$97,891 | $32,128 | $138,736 | -$115,120 |
| EBITDA | $13,570 | $13,703 | $20,187 | $19,255 | $12,424 | $8,671 | — | $6,707 |
| EPS (basic) | 0.00 | -0.00 | 0.00 | — | -0.00 | 0.00 | 0.00 | — |
| EPS (diluted) | 0.00 | -0.00 | 0.00 | — | -0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 206.90M | 206.90M | 206.90M | — | 206.90M | 206.90M | 206.90M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $388,490 | $257,989 | $220,027 | $285,034 | $367,519 | $580,951 | $304,637 | $397,476 |
| Receivables | $31,411 | $19,231 | $75,159 | $17,376 | $38,423 | $55,443 | $63,162 | $74,648 |
| Inventory | $1,733 | $1,734 | $2,301 | $2,347 | $4,025 | $4,296 | $2,860 | $3,350 |
| Current assets | $459,663 | $333,976 | $361,617 | $331,773 | $449,837 | $660,053 | $564,255 | $497,662 |
| PP&E, net | $147,818 | $161,390 | $176,280 | $189,386 | $194,276 | $128,970 | $130,507 | $136,767 |
| Intangibles | $1 | $1 | $149 | $409 | $621 | $873 | $1,140 | $1,401 |
| Total assets | $742,932 | $637,223 | $687,604 | $677,136 | $800,748 | $951,722 | $855,176 | $635,830 |
| Current liabilities | $502,687 | $425,394 | $471,855 | $465,464 | $413,240 | $469,279 | $421,313 | $484,017 |
| Total liabilities | $681,311 | $645,043 | $693,393 | $686,482 | $652,155 | $701,647 | $642,064 | $561,794 |
| Shareholders' equity | $61,621 | -$7,820 | -$5,789 | -$9,346 | $148,593 | $250,075 | $213,112 | $74,036 |
| Shares outstanding | 206.90M | 206.90M | 206.90M | 206.90M | 206.90M | 206.90M | 206.90M | 206.90M |
| Cash flow statement | ||||||||
| Operating cash flow | $91,258 | $49,821 | -$55,119 | -$75,706 | -$167,182 | $233,336 | -$84,751 | -$34,648 |
| Capital expenditure | -$115 | $202 | $146 | $2,969 | $35,670 | $1,046 | $1,346 | $103,921 |
| Free cash flow | $91,373 | $49,619 | -$55,265 | -$78,675 | -$202,852 | $232,290 | -$86,097 | -$138,569 |
| Investing cash flow | $115 | -$202 | -$146 | -$1,800 | -$35,647 | $30,311 | -$1,346 | -$103,945 |
| Financing cash flow | $40,000 | -$8,809 | -$8,849 | -$9,651 | -$7,679 | -$9,176 | -$8,222 | $82,062 |
| Depreciation & amortization | $13,667 | $13,851 | $20,527 | $19,468 | $12,779 | $9,270 | $10,504 | $6,967 |
Free plan shows the latest 8 periods; Pro shows all 46 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.